Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
Why Illumina Stock Just Jumped 10%
02:00pm, Tuesday, 06'th Apr 2021
The DNA sequencing company is gearing up to report a big beat later this month.
Illumina (ILMN) Preliminary Q1 Revenues Rebound, '21 View Up
12:54pm, Tuesday, 06'th Apr 2021
Illumina's (ILMN) revenue improvement in the first quarter is likely to have been boosted by on-going business recovery.
Illumina Stock Pops As Covid Surveillance Helps Drive Unexpected Beat And Raise
10:54am, Tuesday, 06'th Apr 2021
Illumina stock gapped up Tuesday after the company preannounced 26% revenue growth in the first quarter and boosted its full-year guidance. Analysts were split on the preannouncement.
ILMN Jumps Higher on Upbeat Guidance
10:36am, Tuesday, 06'th Apr 2021
The shares of Illumina Inc (NASDAQ:ILMN) are surging today, up 9.2% to trade at $420 at last check, after the company announced better-than-expected preliminary current-quarter and full-year guidance.
Illumina CEO Francis deSouza on first-quarter results, outlook and more
09:28am, Tuesday, 06'th Apr 2021
Illumina issued preliminary current-quarter and full-year guidance that exceeded current analyst estimates. The life sciences company said its projected results are being driven by record orders in it
Illumina Stock Price Increased Over 9% Pre-Market: Why It Happened
08:25am, Tuesday, 06'th Apr 2021
The stock price of Illumina, Inc. (NASDAQ: ILMN) increased by over 9% pre-market. This is why it happened.
Illumina stock rallies 13% after biotech says it expects Q1 sales to top $1 billion
04:46pm, Monday, 05'th Apr 2021
Shares of Illumina Inc. jumped more than 13% in the extended session Monday after the biotech company said it expects first-quarter revenue to top $1 billion thanks to "record" orders and revenue grow
Illumina Announces Preliminary Revenue for First Quarter Fiscal Year 2021
04:30pm, Monday, 05'th Apr 2021
SAN DIEGO--(BUSINESS WIRE)---- $ILMN #ILMN--Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the first quarter of fiscal year 2021 and updated its fiscal year 2021 revenue guidanc
Is Illumina Still a Good Stock to Buy?
08:55am, Monday, 05'th Apr 2021
The company's attempts to grow through acquisition keep running into problems.
Illumina (ILMN) Moves 4.1% Higher: Will This Strength Last?
09:06am, Thursday, 01'st Apr 2021
Illumina (ILMN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro
Canaccord Genuity Ups Ratings on Playboy, BlackBerry, Illumina
12:08pm, Wednesday, 31'st Mar 2021
Analysts at Canaccord Genuity came out Wednesday morning with two rating upgrades, along with initiating coverage with a Buy rating on a third company.
Illumina's (ILMN) Grail Merger in Trouble as FTC Files Suit
09:51am, Wednesday, 31'st Mar 2021
According to FTC, the Illumina (ILMN) and Grail merger will diminish the scope of innovation in the U.S. market for MCED tests.
Despite FTC Challenges Opposing Grail Acquisition, Illumina Committed To Pursue Deal: Report
06:12am, Wednesday, 31'st Mar 2021
The Federal Trade Commission (FTC) is reportedly looking to stop Illumina Inc's (NASDAQ: ILMN) $7.1 billion proposed acquisition of Grail Inc. FTC believes that the deal would slow innovation in canc
The FTC Wants to Block Illumina's Deal For Grail
09:12pm, Tuesday, 30'th Mar 2021
Blood-tests that screen for many kinds of cancer would revolutionize healthcare. Most are being developed for use with Illumina's gene sequencers, so the FTC fears that Illumina's deal to acquire test
Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
03:17pm, Tuesday, 30'th Mar 2021
SAN DIEGO--(BUSINESS WIRE)--Illumina commits to pursuing GRAIL acquisition to accelerate access to breakthrough multi-cancer early detection blood test.
